Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-01-29

Clinical Trial Update: Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial update indicates completion of Phase 2 and Phase 3 studies evaluating the efficacy of oral Lactobacillus rhamnosus GG for Vernal keratoconjun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus rhamnosus GG (Lactobacillus rhamnosus GG)

Snippet

Sponsor: Campus Bio-Medico University | Conditions: Vernal Keratoconjunctivitis | Phase 2, Phase 3 | Status: COMPLETED